TG02 citrate

DRUG3 trials

Sponsors

Tragara Pharmaceuticals, Inc., Lee's Pharmaceutical Limited

Conditions

ALLAMLBlast CrisisChronic Lymphocytic LeukemiaHepatocellular CarcinomaMDSMultiple MyelomaSmall Lymphocytic Lymphoma

Phase 1

Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

CompletedNCT01204164

Tragara Pharmaceuticals, Inc.ALL, AML, Blast Crisis +2

Start: 2010-08-31End: 2016-04-30Target: 120Updated: 2016-05-06

Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

CompletedNCT01699152

Tragara Pharmaceuticals, Inc.Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Start: 2012-09-30End: 2016-05-31Updated: 2019-07-25

Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma

WithdrawnNCT03738111

Lee's Pharmaceutical LimitedHepatocellular Carcinoma

Start: 2018-12-31End: 2021-12-31Updated: 2019-09-25